aXichem AB Class A

As of June 30, 2026, aXichem AB Class A carries a market capitalization of 111.41M, placing it among publicly traded companies globally. Its enterprise value stands at 109.16M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

aXichem AB Class A's next confirmed earnings release is scheduled for November 26, 2026.

As of June 30, 2026, aXichem AB Class A has 67.73M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 6.33, and the price-to-book ratio stands at 2.02.

These figures are as of June 30, 2026. The EV/Sales ratio of 6.71 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 109.16M versus a market cap of 111.41M, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, aXichem AB Class A maintains a current ratio of 3.50, meaning it holds 3.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 1.08, indicating moderate leverage, while an interest coverage ratio of -86.20 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2026, aXichem AB Class A posted a negative return on equity (ROE) of -26.68, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -24.31, reflecting losses generated across the asset base. The company generates approximately 2.32M in revenue per employee across its workforce of 7.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 1.17 indicates how many times aXichem AB Class A sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, aXichem AB Class A recorded 27,000.00 in income tax expense. The company reported a pretax loss of -15.49M and -15.51M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 22, 2026, aXichem AB Class A's stock has declined approximately 26.91% over the past 52 weeks. The 50-day moving average sits at 2.12, while the 200-day moving average is 1.85.

Over the twelve months ended June 30, 2026, aXichem AB Class A generated 16.27M in revenue and converted that into -15.51M in net income, yielding earnings per share of -0.25. EBITDA reached -10.26M, while operating income came in at -15.33M.

As of June 30, 2026, aXichem AB Class A holds 2.87M in cash and equivalents against 595,000.00 in total debt, resulting in a net debt position of -2.28M. Total book value stands at 55.25M, with working capital of 10.46M providing operational flexibility.

aXichem AB Class A produced -7.95M in operating cash flow over the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, aXichem AB Class A posted a gross margin of 50.88, reflecting its pricing power and cost economics. The operating margin of -94.23 and net profit margin of -95.36 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -7.71: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -6.15, meaning aXichem AB Class A raised more capital through share issuance and new debt than it returned via dividends and buybacks.

aXichem AB Class A's most recent stock split took place on February 10, 2026.